Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Lefebvre

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
Molecular Metabolism|January 2, 2025
Intrahepatic levels of microbiome-derived hippurate associates with improved metabolic dysfunction-associated steatotic liver diseaseMaxime Deslande, Francesc Puig-Castellvi, Inés Castro-Dionicio, et al.
Journal of Hepatology|May 25, 2023
Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasisFanny Lalloyer, Denis A Mogilenko, Ann Verrijken, et al.
The Journal of Biological Chemistry|October 10, 2020
CDKN2A/p16INK4a suppresses hepatic fatty acid oxidation through the AMPKα2-SIRT1-PPARα signaling pathwayYann Deleye, Alexia Karen Cotte, Sarah Anissa Hannou, et al.
Antioxidants (Basel, Switzerland)|November 11, 2022
DPP9 as a Potential Novel Mediator in Gastrointestinal Virus InfectionÁngela Del Castillo-Izquierdo, José María Moreno-Navarrete, Jessica Latorre, et al.
JCI Insight|July 7, 2017
Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontinPhilippe Lefebvre, Fanny Lalloyer, Eric Baugé, et al.
Cell Death & Disease|June 3, 2024
O-GlcNAcylation controls pro-fibrotic transcriptional regulatory signaling in myofibroblastsNinon Very, Clémence Boulet, Céline Gheeraert, et al.
Plos Biology|December 12, 2025
Derepression of the epithelial transcription factor GRHL2 promotes direct hepatocyte-to-cholangiocyte transdifferentiationLudivine Vasseur, Céline Gheeraert, Julie Dubois-Chevalier, et al.
Nature Communications|July 3, 2015
Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cellsMohamed-Sami Trabelsi, Mehdi Daoudi, Janne Prawitt, et al.
Molecular Systems Biology|May 15, 2020
Endoplasmic reticulum stress actively suppresses hepatic molecular identity in damaged liverVanessa Dubois, Céline Gheeraert, Wouter Vankrunkelsven, et al.
Nature Medicine|December 9, 2024
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver diseaseVioleta Raverdy, Federica Tavaglione, Estelle Chatelain, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
Molecular Metabolism|January 2, 2025
Intrahepatic levels of microbiome-derived hippurate associates with improved metabolic dysfunction-associated steatotic liver diseaseMaxime Deslande, Francesc Puig-Castellvi, Inés Castro-Dionicio, et al.
Journal of Hepatology|May 25, 2023
Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasisFanny Lalloyer, Denis A Mogilenko, Ann Verrijken, et al.
The Journal of Biological Chemistry|October 10, 2020
CDKN2A/p16INK4a suppresses hepatic fatty acid oxidation through the AMPKα2-SIRT1-PPARα signaling pathwayYann Deleye, Alexia Karen Cotte, Sarah Anissa Hannou, et al.
Antioxidants (Basel, Switzerland)|November 11, 2022
DPP9 as a Potential Novel Mediator in Gastrointestinal Virus InfectionÁngela Del Castillo-Izquierdo, José María Moreno-Navarrete, Jessica Latorre, et al.
JCI Insight|July 7, 2017
Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARα-regulated dermatopontinPhilippe Lefebvre, Fanny Lalloyer, Eric Baugé, et al.
Cell Death & Disease|June 3, 2024
O-GlcNAcylation controls pro-fibrotic transcriptional regulatory signaling in myofibroblastsNinon Very, Clémence Boulet, Céline Gheeraert, et al.
Plos Biology|December 12, 2025
Derepression of the epithelial transcription factor GRHL2 promotes direct hepatocyte-to-cholangiocyte transdifferentiationLudivine Vasseur, Céline Gheeraert, Julie Dubois-Chevalier, et al.
Nature Communications|July 3, 2015
Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cellsMohamed-Sami Trabelsi, Mehdi Daoudi, Janne Prawitt, et al.
Molecular Systems Biology|May 15, 2020
Endoplasmic reticulum stress actively suppresses hepatic molecular identity in damaged liverVanessa Dubois, Céline Gheeraert, Wouter Vankrunkelsven, et al.
Nature Medicine|December 9, 2024
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver diseaseVioleta Raverdy, Federica Tavaglione, Estelle Chatelain, et al.
Pageof 16